JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB9572

Anti-IGF1+IGF2 antibody

4

(8 Reviews)

|

(139 Publications)

Anti-IGF1+IGF2 antibody (ab9572) is a rabbit polyclonal antibody detecting IGF1 in Western Blot, IHC-P, ICC/IF, ELISA, Neut. Suitable for Human, Mouse,.

- Over 110 publications
- Trusted since 2002

View Alternative Names

IBP1, IGF-1, IGF1, Insulin-like growth factor 1, Insulin-like growth factor I, Mechano growth factor, Somatomedin-C, IGF-I, MGF, IGF-2, PP1446, IGF2, Insulin-like growth factor 2, Insulin-like growth factor II, Somatomedin-A, T3M-11-derived growth factor, IGF-II

6 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGF1+IGF2 antibody (AB9572)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGF1+IGF2 antibody (AB9572)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human pancreas tissue labelling IGF1 with ab9572 at 1 μg/mL (45 minute incubation at room temperature). Heat mediated antigen retrieval was performed using a buffer at pH 6. An HRP-labeled polymer detection system was used with a DAB chromogen.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGF1+IGF2 antibody (AB9572)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGF1+IGF2 antibody (AB9572)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human liver tissue labelling IGF1 with ab9572 at 1 μg/mL (45 minute incubation at room temperature). Heat mediated antigen retrieval was performed using a buffer at pH 6. An HRP-labeled polymer detection system was used with a DAB chromogen.

Sandwich ELISA - Anti-IGF1+IGF2 antibody (AB9572)
  • sELISA

Supplier Data

Sandwich ELISA - Anti-IGF1+IGF2 antibody (AB9572)

To detect hIGF-I by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human IGF-I as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIGF-I.

Western blot - Anti-IGF1+IGF2 antibody (AB9572)
  • WB

Lab

Western blot - Anti-IGF1+IGF2 antibody (AB9572)

All lanes:

Western blot - Anti-IGF1+IGF2 antibody (ab9572) at 1/1000 dilution

Lanes 1 and 3:

Mouse IGF-2 recombinant protein (aa25-91, without tag)

Lanes 2 and 4:

Mouse IGF-1 recombinant protein (aa25-91, without tag)

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 22 kDa

false

Exposure time: 59s

Immunohistochemistry - Anti-IGF1+IGF2 antibody (AB9572)
  • IHC

CiteAb

Immunohistochemistry - Anti-IGF1+IGF2 antibody (AB9572)

Immunohistochemistry using Anti-IGF1+IGF2 antibody, ab9572. Publication image from Chéret, J. et al., 2018, Nat Commun, 30228264. Legend direct from paper.

The anagen prolongation effect of Sandalore® is OR2AT4 dependent. a Hair follicle cycle score and staging were performed in HFs treated with siRNA OR2AT4 or scrambled oligos in the presence of Sandalore®32. Representative images of vehicle and treated HFs after 6 days of treatment. Mean ± SEM, n = 16–18 HFs from three donors (independent experiments), Mann–Whitney test, *P < 0.05. b IGF-1 expression was quantified in ORS keratinocytes in treated and vehicle HFs using ImageJ. Representative pictures of IGF-1 immunofluorescence. Mean ± SEM, n = 22–24 HFs from three donors (independent experiments), Mann–Whitney test, *P < 0.05. c, d Ki67+ cells and TUNEL+ cells were counted in the hair matrix of siRNA and control HFs. Representative pictures of Ki67/TUNEL double-staining in the hair bulb of HFs. Mean ± SEM, n = 17–18 HFs from three donors (independent experiments), Mann–Whitney test, *P < 0.05, n.s. not significant. e The number of cleaved caspase-3+ cells (white arrows) in the hair matrix was evaluated in the hair bulb of all HFs treated with OR2AT4-siRNA or scrambled oligos. Representative pictures of cleaved caspase-3 staining. Mean ± SEM, n = 18 HFs from three donors (independent experiments), Student’s t-test, *P < 0.05. CTS connective tissue sheath, DP dermal papilla, HM hair matrix, ORS outer root sheath, IRS inner root sheath. Scale bar : 100 µm

Immunohistochemistry - Anti-IGF1+IGF2 antibody (AB9572)
  • IHC

CiteAb

Immunohistochemistry - Anti-IGF1+IGF2 antibody (AB9572)

Immunohistochemistry using Anti-IGF1+IGF2 antibody, ab9572. Publication image from Chéret, J. et al., 2018, Nat Commun, 30228264. Legend direct from paper.

Hair follicles express OR2AT4, which specific stimulation endorses IGF-1-dependent anagen prolongation. a Representative images showing OR2AT4 protein expression (using the previously published OR2AT4 antibody20) in proximal outer root sheath and hair matrix keratinocytes of human scalp microdissected hair follicles. b Hair cycle score and staging were evaluated in treated and vehicle HFs after 6 days of culture using Ki-67/TUNEL immunofluorescence and Masson–Fontana histochemistry26. Mean ± SEM, n = 16–24 HFs from three donors (independent experiments), Kruskal–Wallis test (P = 0.0923, n.s not significant) and Dunn’s multiple comparisons test as post hoc test, ns not significant, Mann–Whitney test, *P < 0.05. Representative pictures of Masson–Fontana histochemistry in vehicle and treated HFs after 6 days of treatment. c Apoptotic hair matrix keratinocytes were counted in the hair matrix of all treated and vehicle HFs. Representative pictures of Ki67/TUNEL. Mean ± SEM, n = 18–21 HFs from three donors (independent experiments), Kruskal–Wallis (P = 0.005) test and Dunn’s multiple comparisons test as post hoc test, #P < 0.05, ##P < 0.01, ###P < 0.001. d IGF-1 expression was measured in ORS keratinocytes in treated and vehicle HFs. Representative pictures of IGF-1 immunofluorescence. IGF-1 expression was quantified in ORS keratinocytes in treated and vehicle HFs using ImageJ. Mean ± SEM, n = 18–21 HFs from three donors (independent experiments), Kruskal–Wallis (P < 0.001) and Dunn’s multiple comparisons test as post hoc test, ##P < 0.01, ###P < 0.001, and Student’s t-test, *P < 0.05. e Hair cycle score and staging were measured in treated and vehicle HFs after 6 days of culture. Representative pictures of vehicle and treated HFs after 6 days of treatment. Mean ± SEM, n = 22–29 HFs from three donors (independent experiments), Kruskal–Wallis test (P = 0.1434) and Dunn’s multiple comparisons test as post hoc test, n.s not significant, and Student’s t-test after performing an iterative Grubbs outlier test, *P < 0.05. CTS connective tissue sheath, DP dermal papilla, HM hair matrix, ORS outer root sheath, IRS inner root sheath, HS hair shaft. Scale bar : 100 µm

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Light chain type

unknown

Carrier free

No

Reacts with

Human, Mouse

Applications

sELISA, ICC/IF, IHC-FoFr, WB, FuncS (Neut/Block), IHC-P

applications

Immunogen

Recombinant Full Length Protein corresponding to Human IGF1.

P05019

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "sELISA" : {"fullname" : "Sandwich ELISA", "shortname":"sELISA"}, "IHCFoFr" : {"fullname" : "Immunohistochemistry (PFA perfusion fixed frozen sections)", "shortname":"IHC-FoFr"}, "FuncSNeutBlock" : {"fullname" : "Functional Studies (Neut/Block)", "shortname":"FuncS (Neut/Block)"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>To detect hIGF-1 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 μg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-1 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "sELISA-species-checked": "guaranteed", "sELISA-species-dilution-info": "", "sELISA-species-notes": "", "IHCFoFr-species-checked": "guaranteed", "IHCFoFr-species-dilution-info": "", "IHCFoFr-species-notes": "<p></p>", "FuncSNeutBlock-species-checked": "guaranteed", "FuncSNeutBlock-species-dilution-info": "", "FuncSNeutBlock-species-notes": "<p>To yield one-half maximal inhibition of the biological activity of hIGF-1 (5.0 ng/ml), a concentration of 0.67 - 1.0 ug/ml of this antibody is required.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>To detect hIGF-1 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 μg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-1 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.</p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "1 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "sELISA-species-checked": "guaranteed", "sELISA-species-dilution-info": "", "sELISA-species-notes": "<p></p>", "IHCFoFr-species-checked": "guaranteed", "IHCFoFr-species-dilution-info": "", "IHCFoFr-species-notes": "<p></p>", "FuncSNeutBlock-species-checked": "guaranteed", "FuncSNeutBlock-species-dilution-info": "", "FuncSNeutBlock-species-notes": "<p>To yield one-half maximal inhibition of the biological activity of hIGF-1 (5.0 ng/ml), a concentration of 0.67 - 1.0 ug/ml of this antibody is required.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Recombinant fragment - Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>To detect hIGF-1 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-1 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.</p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "sELISA-species-checked": "notRecommended", "sELISA-species-dilution-info": "", "sELISA-species-notes": "", "IHCFoFr-species-checked": "notRecommended", "IHCFoFr-species-dilution-info": "", "IHCFoFr-species-notes": "", "FuncSNeutBlock-species-checked": "notRecommended", "FuncSNeutBlock-species-dilution-info": "", "FuncSNeutBlock-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Recombinant full length protein - Human": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "sELISA-species-checked": "testedAndGuaranteed", "sELISA-species-dilution-info": "0.5-2 µg/mL", "sELISA-species-notes": "<p>Allows for the detection of at least 0.2 - 0.4 ng/well of recombinant IGF1.</p>", "IHCFoFr-species-checked": "notRecommended", "IHCFoFr-species-dilution-info": "", "IHCFoFr-species-notes": "", "FuncSNeutBlock-species-checked": "notRecommended", "FuncSNeutBlock-species-dilution-info": "", "FuncSNeutBlock-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Product Specifications

Anti-IGF1+IGF2 antibody (ab9572) is a rabbit Polyclonal antibody and is validated for use in ICC/IF, IHC-FoFr, IHC-P, Neut, WB, sELISA in human, mouse samples.
Anti-IGF1+IGF2 antibody (ab9572) specifically detects IGF1 + IFG2 (UniProt ID: P05019; Molecular weight: 8kDa) and is sold in 100 µg selling sizes.

Quality and Validation

Abcam's high quality validation processes ensure Anti-IGF1+IGF2 antibody (ab9572) has high sensitivity and specificity.
Anti-IGF1+IGF2 antibody (ab9572) has been cited over 114 times in peer reviewed journals and is trusted by the scientific community.

Although some customers have been successful in IHC we no longer batch test in this application. For an IHC validated antibody please see ab263903
Anti-IGF1+IGF2 antibody (ab9572) has 8 independent reviews from customers.

Properties and storage information

Form
Lyophilized
Reconstitution
Reconstitute with 200µl of sterile water. Please note that if you receive this product in liquid form it has already been reconstituted as described and no further reconstitution is necessary.
Purification technique
Affinity purification Immunogen
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation (PubMed : 21076856, PubMed : 24132240). Ca(2+)-dependent exocytosis of IGF1 is required for sensory perception of smell in the olfactory bulb (By similarity). Acts as a ligand for IGF1R. Binds to the alpha subunit of IGF1R, leading to the activation of the intrinsic tyrosine kinase activity which autophosphorylates tyrosine residues in the beta subunit thus initiating a cascade of down-stream signaling events leading to activation of the PI3K-AKT/PKB and the Ras-MAPK pathways. Binds to integrins ITGAV : ITGB3 and ITGA6 : ITGB4. Its binding to integrins and subsequent ternary complex formation with integrins and IGFR1 are essential for IGF1 signaling. Induces the phosphorylation and activation of IGFR1, MAPK3/ERK1, MAPK1/ERK2 and AKT1 (PubMed : 19578119, PubMed : 22351760, PubMed : 23243309, PubMed : 23696648). As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via promotion of STUB1/CHIP-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity).
See full target information IGF1

Additional targets

IGF2

Publications (139)

Recent publications for all applications. Explore the full list and refine your search

Medicina (Kaunas, Lithuania) 61: PubMed40870495

2025

Non-Obstructive Azoospermia: Influence of PRP on Proliferation, Apoptosis, and Growth Factors of Male Germ Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Grigory Demyashkin,Vladimir Shchekin,Maya Epifanova,Tatyana Borovaya,Matvey Vadyukhin,Konstantin Gotovtsev,Petr Shegay,Andrey Kaprin

Nature 646:676-686 PubMed40770097

2025

Microglia regulate GABAergic neurogenesis in prenatal human brain through IGF1.

Applications

Unspecified application

Species

Unspecified reactive species

Diankun Yu,Samhita Jain,Andi Wangzhou,Beika Zhu,Wenyuan Shao,Elena J Coley-O'Rourke,Stacy De Florencio,JaeYeon Kim,Jennifer Ja-Yoon Choi,Mercedes F Paredes,Tomasz J Nowakowski,Eric J Huang,Xianhua Piao

BMC pediatrics 25:288 PubMed40221697

2025

Gene proteins, growth factors/their receptors in the wall of chronic calculous cholecystitis-affected gallbladder children.

Applications

Unspecified application

Species

Unspecified reactive species

Darja Derbeneva,Mara Pilmane,Aigars Petersons

Journal of ovarian research 18:6 PubMed39806494

2025

Long non-coding RNA NEAT1 promotes ovarian granulosa cell proliferation and cell cycle progression via the miR-29a-3p/IGF1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Lina He,Jie Lin,Zhengwen Qin,Qing Xu,Li Hao,Yanhong Fu,Xu Ran,Wei Chen

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 22:e00477 PubMed39516073

2024

IGF-1 impacts neocortical interneuron connectivity in epileptic spasm generation and resolution.

Applications

Unspecified application

Species

Unspecified reactive species

Carlos J Ballester-Rosado,John T Le,Trang T Lam,Anne E Anderson,James D Frost,John W Swann

Nature communications 15:9170 PubMed39448593

2024

IGF1 drives Wnt-induced joint damage and is a potential therapeutic target for osteoarthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Ana Escribano-Núñez,Frederique M F Cornelis,Astrid De Roover,An Sermon,Frédéric Cailotto,Rik J Lories,Silvia Monteagudo

The journal of headache and pain 25:156 PubMed39304806

2024

Targeting IGF1/IGF1r signaling relieve pain and autophagic dysfunction in NTG-induced chronic migraine model of mice.

Applications

Unspecified application

Species

Unspecified reactive species

Tianxiao Wang,Chenlu Zhu,Kaibo Zhang,Jinggui Gao,Yunhao Xu,Chenyang Duan,Shouyi Wu,Cheng Peng,Jisong Guan,Yonggang Wang

Materials today. Bio 28:101170 PubMed39211290

2024

Unveiling the governing role of 'remodeling triangle area' in soft-hard tissue interface equilibrium for metal implants advancement.

Applications

Unspecified application

Species

Unspecified reactive species

Shoucheng Chen,Guangqi Gao,Jiamin Shi,Na Li,Lv Xie,Yingye Zhang,Zhengjie Shan,Jiaxin Xie,Yin Xiao,Zhuofan Chen,Zetao Chen

American journal of clinical and experimental urology 12:64-87 PubMed38736619

2024

Urine-derived stem cells genetically modified with IGF1 improve muscle regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Hualin Yi,Gang Chen,Shuai Qiu,Joshua T Maxwell,Guiting Lin,Tracy Criswell,Yuanyuan Zhang

Reproduction, fertility, and development 36: PubMed38739740

2024

Maternal high-fat diet during pregnancy and lactation affects factors that regulate cell proliferation and apoptosis in the testis of adult progeny.

Applications

Unspecified application

Species

Unspecified reactive species

Helen Viotti,Daniel Cavestany,Graeme B Martin,Mark H Vickers,Deborah M Sloboda,Graciela Pedrana
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com